Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth

Summary

GBI Research has released its Chemical research, “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth”. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, product type analysis, drivers and restraints, analysis of the therapeutic categories and a market share analysis of the major producers in the important geographical markets of the world. In addition, it includes market forecasts, product type analysis and therapeutic categories analysis of the APIs in major countries of the world. Overall, the report presents a comprehensive analysis of the global API market covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

North America and Europe together account for more than 60% share in the global API market revenue. Asia-Pacific is the fastest growing API market in the world. The global API demand is led by China, India and Brazil. The innovator APIs are increasingly losing market share to generic sector APIs. On the basis of synthesis route, the synthetic APIs continue to dominate the global revenues. However, the growth in biotech APIs is expected to be faster in the forecast period.

The global API sales revenue was $91 billion in 2009 and is expected to grow at a CAGR of 5.9% from 2010 to 2015. The growth will be driven by the rise in demand of generic sector drugs and biological drugs. The recovery from economic slowdown will help the global API market to grow. The global API sales revenue is expected to reach $126.3 billion in 2015.

Scope

- Market revenue data for APIs from 2005 to 2009 and forecast for six years to 2015.
- API markets in key regions: North America, Europe, Asia-Pacific and South and Central America.
- API markets in key countries: the US, Canada, Germany, the UK, France, Italy, Spain, Japan, China, India, Mexico and Brazil.
- Drivers of the API market such as growth in generic drugs and biotech drugs, and restraints such as economic slowdown and patent expiries, for the global market as well as for regional markets.
- Information on the competitive landscape with the shares of leading companies such as Pfizer Inc, AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Sanofi Aventis and Novartis.
- Analysis of API revenue by product type in the global market, in key regions and countries
- Analysis of API revenue by therapeutic category in the key countries.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global APIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the APIs market.
- Identify macro and micro-economic trends shaping and driving the global APIs market.

Table Of Contents

1 Table of Contents 4
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 GBI Report Coverage 12
3 Global API Market 13
3.1 Global API Industry Structure 13
3.2 Global API Industry Challenges 14
3.2.1 Maturity of the Market in Developed Regions Restricts the Global API Revenue Growth 14
3.2.2 High Cost of New Drug Development Becomes a Hurdle to Innovation 14
3.2.3 Highly Fragmented Nature of Market Leads to Intense Competition and Price Decline 14
3.2.4 Regulatory Challenges Delay the Launch of Drugs 14
3.3 Global API Market Overview 14
3.4 Global API Market Revenue Analysis and Forecasts to 2015 15
3.5 Global API Market Revenue Share Analysis by Product Type and Forecasts to 2015 17
3.5.1 Global API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015 18
3.5.2 Global API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 19
3.6 Global API Revenue Share Analysis by Region and Forecasts to 2015 20
3.7 Global API Market Competitive Landscape 21
4 North America API Market 23
4.1 North America API Market Overview 23
4.2 North America API Market Drivers 23
4.2.1 Growth in the Generic Sector is Leading the Overall Growth in Demand for APIs in the Region 23
4.2.2 Increasing Focus on Biological Drugs Contributes to the Growth of API Demand in the Region 23
4.2.3 The Rising Incidence of Lifestyle and Older Age Diseases is Giving Rise to API Demand in the Region 23
4.2.4 Growth in Oncology is one of the Major Contributing Factors to the Growth of APIs in the Region 23
4.2.5 Increasing Focus on High Potency APIs Helps the Market Growth 24
4.3 North America API Market Restraints 24
4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the Region 24
4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of North American API Market 24
4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversly Affect the Growth of API Market in the Region 24
4.3.4 Rising Competition from China and India is Creating Price Pressure in the North American Market 24
4.4 North America API Market Revenue Analysis and Forecasts to 2015 25
4.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2015 27
4.5.1 North America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015 27
4.5.2 North America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 28
4.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2015 29
4.7 North America API Market Competitive Landscape 30
4.8 The US API Market 31
4.8.1 The US API Market Overview 31
4.8.2 The US API Market Revenue Analysis and Forecasts to 2015 32
4.8.3 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015 33
4.8.4 The US API Market Revenue Share Analysis by Therapeutic Category 35
4.9 Canada API Market 36
4.9.1 Canada API Market Overview 36
4.9.2 Canada API Market Revenue Analysis and Forecasts to 2015 37
4.9.3 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015 38
4.9.4 Canada API Market Revenue Share Analysis by Therapeutic Category 40
5 Europe API Market 42
5.1 Europe API Market Overview 42
5.2 Europe API Market Drivers 42
5.2.1 Rising Demand in the Generic Sector Forces the API Market to Grow in the Region 42
5.2.2 Increasing Focus on Biopharmaceuticals Encourages the Growth in the API Market 42
5.2.3 Rising Incidences of Lifestyle Diseases and Older Age Diseases in the Region Enable the Growth in API Market 42
5.2.4 Growth in Oncology Contributes to the API Market growth in the Region 42
5.2.5 Increasing Focus on HPAPI Helps the Overall API Revenue Growth 42
5.2.6 Increasing Number of Development Projects in Therapeutic Peptide Area 43
5.3 Europe API Market Restraints 43
5.3.1 The Economic Slowdown is Hampering the Overall Pharmaceutical Market in the Region 43
5.3.2 Large Number of Patent Expiries Will Lead to Reduced Growth in the Region’s API Market 43
5.3.3 Decreasing Focus on Innovator Drug Sector Restricts the Overall API Market Revenue 43
5.3.4 Price Erosion in the API Market is Hindering the Revenue Growth 43
5.4 Europe API Market Revenue Analysis and Forecasts to 2015 44
5.5 Europe API Market Revenue Share Analysis by Product Type and Forecasts to 2015 45
5.5.1 Europe API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015 45
5.5.2 Europe API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 46
5.6 Europe API Market Revenue Share Analysis by Country and Forecasts to 2015 47
5.7 Europe API Market Competitive Landscape 48
5.8 Germany API Market 49
5.8.1 Germany API Market Overview 49
5.8.2 Germany API Market Revenue Analysis and Forecasts to 2015 50
5.8.3 Germany API Market Revenue Share Analysis by Product Type and Forecasts to 2015 51
5.8.4 Germany API Market Revenue Share Analysis by Therapeutic Category 53
5.9 The UK, API Market 54
5.9.1 The UK, API Market, Overview 54
5.9.2 The UK API Market Revenue Analysis and Forecasts to 2015 54
5.9.3 The UK API Market Revenue Share Analysis by Product Type and Forecasts to 2015 55
5.9.4 The UK API Market Revenue Share Analysis by Therapeutic Category 57
5.10 France API Market 58
5.10.1 France API Market Overview 58
5.10.2 France API Market Revenue Analysis and Forecasts to 2015 58
5.10.3 France Market Revenue Share Analysis by Product Type and Forecasts to 2015 60
5.10.4 France API Market Revenue Share Analysis by Therapeutic Category 62
5.11 Italy API Market 63
5.11.1 Italy API Market Overview 63
5.11.2 Italy API Market Revenue Analysis and Forecasts to 2015 63
5.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecasts to 2015 65
5.11.4 Italy API Market Revenue Share Analysis by Therapeutic Category 67
5.12 Spain API Market 68
5.12.1 Spain API Market Overview 68
5.12.2 Spain API Market Revenue Analysis and Forecasts to 2015 69
5.12.3 Spain API Market Revenue Share Analysis by Product Type and Forecasts to 2015 70
5.12.4 Spain API Market Revenue Share Analysis by Therapeutic Category 72
6 Asia-Pacific API Market 73
6.1 Asia-Pacific API Market Overview 73
6.2 Asia-Pacific API Market Drivers 73
6.2.1 Rapidly Growing Economies of China and India Favour the Growth in the Region’s API Market Revenue 73
6.2.2 The Booming Generic Drug Sector is Leading the Growth of API Market in Asia Pacific 73
6.2.3 Increasing Demand of Innovator Drugs Contributes to the Revenue Growth in the Region’s API Market 73
6.2.4 Growth in the Development of Biotech Drugs Helps API Market Revenue to Grow in the Region 74
6.2.5 Peptide APIs Offer Growth Opportunities to the Asia-Pacific’s API Market 74
6.2.6 Government’s Plan to Develop Multi-level Insurance System in China is Set to Boost the Growth of the API Market 74
6.3 Asia-Pacific API Market Restraints 74
6.3.1 Rising Competition is Leading to Price Erosion Which Affects the Revenue Growth in the API Market of the Region 74
6.3.2 Fluctuations in the Prices Acts as a Hurdle in the Revenue Growth 74
6.3.3 Surplus Capacity May Emerge as a Challenge for Producers in China and India 74
6.3.4 The Global Economic Slowdown has Reduced the Demand in the API Market 75
6.4 Asia-Pacific API Market Revenue Analysis and Forecasts to 2015 75
6.5 Asia-Pacific API Market Revenue Share Analysis by Product Type and Forecasts to 2015 77
6.5.1 Asia-Pacific, API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015 77
6.5.2 Asia-Pacific API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 78
6.6 Asia-Pacific API Market Revenue Share Analysis by Country and Forecasts to 2015 79
6.7 Asia-Pacific API Market Competitive Landscape 80
6.8 Japan API Market 81
6.8.1 Japan API Market Overview 81
6.8.2 Japan API Market Revenue Analysis and Forecasts to 2015 81
6.8.3 Japan API Market Revenue Share Analysis by Product Type and Forecasts to 2015 82
6.8.4 Japan API Market Revenue Share Analysis by Therapeutic Category 84
6.9 China API Market 85
6.9.1 China API Market Overview 85
6.9.2 China API Market Revenue Analysis and Forecasts to 2015 86
6.9.3 China API Market Revenue Share Analysis by Product Type and Forecasts to 2015 87
6.9.4 China API Market Revenue Share Analysis by Therapeutic Category 89
6.10 India API Market 90
6.10.1 India API Market Overview 90
6.10.2 India API Market Revenue Analysis and Forecasts to 2015 91
6.10.3 India API Market Revenue Share Analysis by Product Type and Forecasts to 2015 92
6.10.4 India API Market Revenue Share Analysis by Therapeutic Category 94
7 South and Central America API Market 96
7.1 South and Central America API Market Overview 96
7.2 South and Central America API Market Drivers 96
7.2.1 Rapidly Growing Brazilian Economy Boosts the Overall API Market Growth in the Region 96
7.2.2 Growth in the Generic Sector Augments the Overall API Market Growth 96
7.2.3 Growth in Biotechnology Adds Significantly to the Growth of API Market in the Region 96
7.2.4 Increasing Ageing Population, Changing Demographics and Lifestyle Helps Growth in the API Market of the Region 96
7.3 South and Central America API Market Restraints 96
7.3.1 Economic Slowdown has Hampered the Growth of Pharmaceutical Market in the Region 96
7.3.2 The Slowdown in the Innovator Drugs Market in the Region has Affected the Overall API Market Growth 97
7.3.3 Declining Prices Restricts the Revenue Growth of the API Market in the Region 97
7.4 South and Central America API Market Revenue Analysis and Forecasts to 2015 97
7.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2015 98
7.5.1 South and Central America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015 98
7.5.2 South and Central America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 99
7.6 South and Central America API Market Revenue by Country and Forecasts to 2015 100
7.7 South and Central America API Market Competitive Landscape 101
7.8 Mexico API Market 101
7.8.1 Mexico API Market Overview 101
7.8.2 Mexico API Market Revenue Analysis and Forecasts to 2015 102
7.8.3 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2015 103
7.8.4 Mexico API Market Revenue Share Analysis by Therapeutic Category 105
7.9 Brazil API Market 106
7.9.1 Brazil API Market Overview 106
7.9.2 Brazil API Market Revenue Analysis and Forecasts to 2015 107
7.9.3 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2015 108
7.9.4 Brazil API Market Revenue Share Analysis by Therapeutic Category 110
8 Appendix 112
8.1 Market Definitions 112
8.2 Abbreviations 112
8.3 Methodology 112
8.3.1 Coverage 112
8.3.2 Secondary Research 113
8.3.3 Primary Research 113
8.3.4 Expert Panel Validation 113
8.4 Contact Us 113
8.5 About GBI Research 113
8.6 Disclaimer 114

1.1 List of Tables
Table 1: API Market, Global, Revenues, $m, 2005-2015 16
Table 2: API Market, Global, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 18
Table 3: API Market, Global, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 19
Table 4: API Market, Global, Revenue Share Analysis by Region, %, 2009-2015 21
Table 5: API Market, Global, Revenue Share Analysis by Company, 2009 22
Table 6: API Market, North America, Revenues, $m, 2005-2015 26
Table 7: API Market, North America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 27
Table 8: API Market, North America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 28
Table 9: API Market, North America, Revenue Share Analysis by Country, %, 2009 and 2015 29
Table 10: API Market, North America, Revenue Share Analysis by Company, 2009 31
Table 11: API Market, The US, Revenues, $m, 2005-2015 32
Table 12: API Market, The US, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 33
Table 13: API Market, The US, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 34
Table 14: API Market, The US, Revenue Shares by Therapeutic Category, %, 2009 36
Table 15: API Market, Canada, Revenues, $m, 2005-2015 37
Table 16: API Market, Canada, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 38
Table 17: API Market, Canada, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 39
Table 18: API Market, Canada, Revenue Share Analysis by Therapeutic Category, %, 2009 41
Table 19: API Market, Europe, Revenues, $m, 2005-2015 44
Table 20: API Market, Europe, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 45
Table 21: API Market, Europe, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009-2015 46
Table 22: API Market, Europe, Revenue Share Analysis by Country, %, $m, 2009-2015 48
Table 23: API Market, Europe, Revenue Share Analysis by Company, %, 2009 49
Table 24: API Market, Germany, Revenues, $m, 2005-2015 51
Table 25: API Market, Germany, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 52
Table 26: API Market, Germany, Revenue Share Analysis by Product Type Based on Generic Sector, %, 2009 and 2015 52
Table 27: API Market, Germany, Revenue Share Analysis by Therapeutic Category, %, 2009 53
Table 28: API Market, The UK, Revenues, $m, 2005-2015 55
Table 29: API Market, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 56
Table 30: API Market, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 56
Table 31: API Market, The UK, Revenue Share Analysis by Therapeutic Category, %, 2009 57
Table 32: API Market, France, Revenues, $m, 2005-2015 59
Table 33: API Market, France, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 60
Table 34: API Market, France, Revenue Share Analysis by Product Type Based on Innovator and Generic Sector, %, 2009 and 2015 61
Table 35: API Market, France, Revenue Share Analysis by Therapeutic Category, %, 2009 62
Table 36: API Market, Italy, Revenues, $m, 2005-2015 64
Table 37: API Market, Italy, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 65
Table 38: API Market, Italy, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 66
Table 39: API Market, Italy, Revenue Share Analysis by Therapeutic Category, %, 2009 68
Table 40: API Market, Spain, Revenues, $m, 2005-2015 69
Table 41: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector Spanish, %, 2009 and 2015 70
Table 42: API Market, Revenue Share Analysis by Product Type Based on Innovator and Generic sector APIs in the Spanish, %, 2009 and 2015 71
Table 43: API Market, Spain, Revenue Share Analysis by Therapeutic Category, %, 2009 72
Table 44: API Market, Asia-Pacific, Revenues, $m, 2005-2015 76
Table 45: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 77
Table 46: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 78
Table 47: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2009 and 2015 79
Table 48: API Market, Japan, Revenues, $m, 2005-2015 82
Table 49: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 83
Table 50: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 83
Table 51: API Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2009 85
Table 52: API Market, China, Revenues, $m, 2005-2015 86
Table 53: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 87
Table 54: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 88
Table 55: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2009 90
Table 56: API Market, India, Revenues, $m, 2005-2015 91
Table 57: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 92
Table 58: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 93
Table 59: API Market, India, Revenue Share Analysis by Therapeutic Category, %, 2009 95
Table 60: API Market, South and Central America, Revenues, $m, 2005-2015 98
Table 61: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 99
Table 62: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009-2015 99
Table 63: API Market, South and Central America, Revenue Share Analysis by Country, %, 2009-2015 100
Table 64: API Market, Mexico, Revenues, $m, 2005-2015 102
Table 65: API Market, Mexico, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 103
Table 66: API Market, Mexico, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 104
Table 67: API Market, Mexico, Revenue Share Analysis by Therapeutic Category, %, 2009 106
Table 68: API Market, Brazil, Revenues, $m, 2005-2015 108
Table 69: API Market, Brazil, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 109
Table 70: API Market, Brazil, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 109
Table 71: API Market, Brazil, Revenue Share Analysis by Therapeutic Category, %, 2009 111

1.2 List of Figures
Figure 1: API, Global, Industry Value Chain, 2009 13
Figure 2: API Market, Global, Revenues, $m, 2005-2015 15
Figure 3: API Market, Global, Product Type, 2009 17
Figure 4: API Market, Global, Revenue Share Analysis by Synthesis Route, %, 2009 and 2015 18
Figure 5: API Market, Global, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 19
Figure 6: API Market, Global, Revenue Share Analysis by Region, %, 2009 and 2015 20
Figure 7: API Market, Global, Revenue by Share Analysis by Company, 2009 21
Figure 8: API Market, North America, Revenues, $m, 2005-2015 25
Figure 9: API Market, North America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 27
Figure 10: API Market, North America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 28
Figure 11: API Market, North America, Revenue Share Analysis by Country, %, 2009 and 2015 29
Figure 12: API Market, North America, Revenue Share Analysis by Company, 2009 30
Figure 13: API Market, The US, Revenues, $m, 2005-2015 32
Figure 14: API Market, The US, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 33
Figure 15: API Market, The US, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 34
Figure 16: API Market, The US, Revenue Shares by Therapeutic Category, %, 2009 35
Figure 17: API Market, Canada, Revenues, $m, 2005-2015 37
Figure 18: API Market, Canada, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 38
Figure 19: API Market, Canada, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 39
Figure 20: API Market, Canada, Revenue Share Analysis by Therapeutic Category, %, 2009 40
Figure 21: API Market, Europe, Revenues, $m, 2005-2015 44
Figure 22: API Market, Europe, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 45
Figure 23: API Market, Europe, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 46
Figure 24: API Market, Europe, Revenue Share Analysis by Country, %, 2009 and 2015 47
Figure 25: API Market, Europe, Revenue Share Analysis by Company, %, 2009 48
Figure 26: API Market, Germany, Revenues, $m, 2005-2015 50
Figure 27: API Market, Germany, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 51
Figure 28: API Market, Germany, Revenue Share Analysis by Product Type Based on Generic Sector, %, 2009 and 2015 52
Figure 29: API Market, Germany, Revenue Share Analysis by Therapeutic Category, %, 2009 53
Figure 30: API Market, The UK, Revenues, $m, 2005-2015 54
Figure 31: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector, %, 2009 and 2015 55
Figure 32: API Market, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 56
Figure 33: API Market, The UK, Revenue Share Analysis by Therapeutic Category, %, 2009 57
Figure 34: API Market, France, Revenues, $m, 2005-2015 58
Figure 35: API Market, France, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 60
Figure 36: API Market, France, Revenue Share Analysis by Product Type Based on Innovator and Generic Sector, %, 2009 and 2015 61
Figure 37: API Market, France, Revenue Share Analysis by Therapeutic Category, %, 2009 62
Figure 38: API Market, Italy, Revenues, $m, 2005-2015 63
Figure 39: API Market, Italy, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 65
Figure 40: API Market, Italy, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 66
Figure 41: API Market, Italy, Revenue Share Analysis by Therapeutic Category, %, 2009 67
Figure 42: API Market, Spain, Revenues, $m, 2005-2015 69
Figure 43: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector Spanish, %, 2009 and 2015 70
Figure 44: API Market, Revenue Share Analysis by Product Type Based on Innovator and Generic sector APIs in the Spanish, %, 2009 and 2015 71
Figure 45: API Market, Spain, Revenue Share Analysis by Therapeutic Category, %, 2009 72
Figure 46: API Market, Asia-Pacific, Revenues, $m, 2005-2015 75
Figure 47: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 77
Figure 48: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 78
Figure 49: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2009 and 2015 79
Figure 50: API Market, Japan, Revenues, $m, 2005-2015 81
Figure 51: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 82
Figure 52: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 83
Figure 53: API Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2009 84
Figure 54: API Market, China, Revenues, $m, 2005-2015 86
Figure 55: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 87
Figure 56: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 88
Figure 57: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2009 89
Figure 58: API Market, India, Revenues, $m, 2005-2015 91
Figure 59: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 92
Figure 60: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 93
Figure 61: API Market, India, Revenue Share Analysis by Therapeutic Category, %, 2009 94
Figure 62: API Market, South and Central America, Revenues, $m, 2005-2015 97
Figure 63: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 98
Figure 64: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 99
Figure 65: API Market, South and Central America, Revenue Share Analysis by Country, %, 2009-2015 100
Figure 66: API Market, Mexico, Revenues, $m, 2005-2015 102
Figure 67: API Market, Mexico, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 103
Figure 68: API Market, Mexico, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 104
Figure 69: API Market, Mexico, Revenue Share Analysis by Therapeutic Category, %, 2009 105
Figure 70: API Market, Brazil, Revenues, $m, 2005-2015 107
Figure 71: API Market, Brazil, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 108
Figure 72: API Market, Brazil, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 109
Figure 73: API Market, Brazil, Revenue Share Analysis by Therapeutic Category, %, 2009 110

Companies mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • May 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

  • $ 495
  • Industry report
  • April 2014
  • by MarketLine

Introduction In October 2013, Teva announced that it would be cutting approximately 10% of the workforce in order to cut costs. Later that month, it announced the departure of its CEO of just 18 months, ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Hyaluronic Market 2012-2016

October 2013 $ 2 500

Global Generics, Marketline

August 2013 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.